Viewing Study NCT01073904


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2025-12-29 @ 10:11 PM
Study NCT ID: NCT01073904
Status: COMPLETED
Last Update Posted: 2014-04-03
First Post: 2010-02-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module